You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Checkpoint Inhibition

Showing 1 - 25 of 3,844
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anti-cancer Immune Checkpoint Inhibition TowardsBetter

Not yet recruiting
  • Cancer
    • (no location specified)
    Aug 1, 2023

    And Immuno-meDIated Adverse Events in Anti-cancer

    Not yet recruiting
    • Cancer
      • (no location specified)
      Jun 26, 2023

      Fibrolamellar Hepatocellular Carcinoma Trial in Tuebingen (Fusion-VAC-XS15)

      Not yet recruiting
      • Fibrolamellar Hepatocellular Carcinoma
      • Tuebingen, Baden-Würtemberg, Germany
        University Hospital Tuebingen
      Jun 29, 2023

      ImPACt on Invasive Fungal Infections by Immune Checkpoint

      Completed
      • Invasive Fungal Infections
      • No intervention
      • Köln, Germany
        Klinikum der Universität zu Köln
      Oct 31, 2022

      Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)

      Not yet recruiting
      • Oligometastatic Prostate Cancer
      • New York, New York
        Columbia University Irving Medical Center / NewYork-Presbyterian
      Jun 14, 2023

      Cutaneous Malignant Melanoma Trial in Cleveland (Low Dose Rate Brachytherapy (LDR), Standard-of-Care Immunotherapy)

      Recruiting
      • Cutaneous Malignant Melanoma
      • Low Dose Rate Brachytherapy (LDR)
      • Standard-of-Care Immunotherapy
      • Cleveland, Ohio
        Cleveland Clinic, Case Comprehensive Cancer Center
      Aug 10, 2022

      Colon Carcinoma Trial in Netherlands (Nivolumab, Ipilimumab, Celecoxib 200mg)

      Recruiting
      • Colon Carcinoma
      • Amsterdam, Netherlands
      • +5 more
      Jan 23, 2023

      Colorectal Cancer, Colorectal Carcinoma, Colorectal Adenocarcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Pexa-Vec)

      Active, not recruiting
      Has Results
      • Colorectal Cancer
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 24, 2023

      Small-cell Lung Cancer, Relapsed Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer Trial in Kissimmee, Tampa (Nivolumab,

      Recruiting
      • Small-cell Lung Cancer
      • +2 more
      • Kissimmee, Florida
      • +1 more
      Nov 2, 2022

      Ovarian Cancer Trial in Houston (Nivolumab, Etigilimab)

      Not yet recruiting
      • Ovarian Cancer
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 27, 2023

      Glioblastoma, Gliosarcoma, Malignant Glioma Trial run by the NCI (TMZ, ipilimumab 3mg/kg, Nivolumab)

      Recruiting
      • Glioblastoma
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 31, 2023

      Cutaneous Metastases Trial in New York (Diphencyprone (DPCP))

      Not yet recruiting
      • Cutaneous Metastases
      • Diphencyprone (DPCP)
      • New York, New York
        Icahn School of Medicine at Mount Sinai
      Jul 28, 2022

      Malignant Pleural Mesothelioma Trial in Philadelphia (OT-101)

      Not yet recruiting
      • Malignant Pleural Mesothelioma
      • Philadelphia, Pennsylvania
        University of Pennsylvania
      Jun 16, 2022

      Liver Metastases, NSCLC Trial in Ann Arbor (Liver SBRT, Pembrolizumab)

      Recruiting
      • Liver Metastases
      • Non-small Cell Lung Cancer
      • Ann Arbor, Michigan
        Veterans Affairs Ann Arbor Healthcare System
      Jul 27, 2022

      NSCLC, NSCLC Stage IV Trial in Madison (Durvalumab, Tremelimumab, Stereotactic Body Radiotherapy)

      Active, not recruiting
      • Non-small Cell Lung Cancer
      • Non-small Cell Lung Cancer Stage IV
      • Madison, Wisconsin
        University of Wisconsin Carbone Cancer Center
      Sep 21, 2022

      Brain Metastases, Non Small Cell Lung Cancer Trial in Durham (Stereotactic Radiosurgery, Immunotherapy)

      Recruiting
      • Brain Metastases
      • Non Small Cell Lung Cancer
      • Durham, North Carolina
        Duke Cancer Center
      Jun 6, 2022

      Colon Cancer, Liver Metastasis Colon Cancer, Rectal Cancer Trial in Ramat Gan (Hepatopulmonary radio-sterilization)

      Not yet recruiting
      • Colon Cancer
      • +2 more
      • Hepatopulmonary radio-sterilization
      • Ramat Gan, Israel
        Sheba Medical Center
      Sep 21, 2023

      NSCLC Stage IV, Melanoma Stage IV, Unresectable Melanoma Trial in Montréal (Camu Camu Capsules (Camu Camu powder encapsulated

      Recruiting
      • NSCLC Stage IV
      • +3 more
      • Camu Camu Capsules (Camu Camu powder encapsulated (500mg each) + ICI
      • Montréal, Quebec, Canada
        Centre hospitalier de l'Université de Montréal (CHUM)
      Jul 18, 2022

      Pancreas Cancer Trial (Nivolumab, Irreversible electroporation (IRE))

      Not yet recruiting
      • Pancreas Cancer
      • (no location specified)
      Jun 27, 2022

      Breast Cancer Trial in Los Angeles (Pembrolizumab, Olaparib)

      Active, not recruiting
      • Breast Cancer
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Feb 1, 2023

      Metastatic Pancreatic Cancer, Metastatic Biliary Tract Cancer Trial in Herlev (Nivolumab, Ipilimumab, Radiotherapy)

      Active, not recruiting
      • Metastatic Pancreatic Cancer
      • Metastatic Biliary Tract Cancer
      • Herlev, Denmark
        Herlev & Gentofte Hospital
      Mar 29, 2022

      Osteosarcoma, Ewing Sarcoma, Rhabdomyosarcoma Trial in Washington (Cryoablation Therapy, Nivolumab, Ipilimumab)

      Recruiting
      • Osteosarcoma
      • +9 more
      • Cryoablation Therapy
      • +2 more
      • Washington, District of Columbia
        Children's National Hospital
      Mar 21, 2022

      Renal Cell Carcinoma, Melanoma Trial (Nivolumab, Pembrolizumab)

      Not yet recruiting
      • Renal Cell Carcinoma
      • Melanoma
      • (no location specified)
      Oct 7, 2021

      Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and

      Recruiting
      • Leptomeningeal Metastasis
      • +2 more
      • intrathecal nivolumab and intrathecal ipilimumab
      • Geneva, Switzerland
      • +2 more
      Dec 18, 2022

      Biliary Tract Tumors, Liver Cancer, Hepatocellular Carcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Trans-arterial

      Active, not recruiting
      Has Results
      • Biliary Tract Neoplasms
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Mar 1, 2022